Clinical Trial Update: Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE) [Phase 4]

View source ↗

Summary

The fAMHOPE Phase 4 clinical trial evaluating controlled ovarian stimulation in newly diagnosed breast cancer patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Erasme University Hospital | Conditions: Breast Neoplasm Malignant Female | Phase 4 | Status: TERMINATED